Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19)-Reference-Cited by-同舟云学术

Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19)

Published:2020-11-12 Issue: Volume:2020 Page:1-4
ISSN:2090-6897
Container-title:Case Reports in Rheumatology
language:en
Short-container-title:Case Reports in Rheumatology

Author:

Tiendrébéogo Wendlassida Joëlle Stéphanie¹^ORCID,Kaboré Fulgence¹^ORCID,Diendéré Eric Arnaud²^ORCID,Ouedraogo Dieu-Donné¹^ORCID

Affiliation:

1. Department of Rheumatology, University Hospital of Bogodogo, Ouagadougou, Burkina Faso

2. Department of Internal Medicine (Infectious Unity), University Hospital of Bogodogo, Ouagadougou, Burkina Faso

Abstract

Coronavirus disease 2019 (COVID-19) is a viral infection that appeared in December 2019. The risk of infection seems to be increased in chronic inflammatory rheumatic diseases due to both immune disturbances related to the disease and treatment. In this case report, we describe the clinical features of 5 rheumatic immune disease patients with the concomitant presence of COVID-19. Among these patients, 3 had rheumatoid arthritis and 2 had systemic lupus erythematosus. Patients’ age ranged between 38 and 63 years. Only one patient (SLE) had a severe subtype of COVID-19. All the patients were cured of COVID-19 and were subsequently discharged.

Publisher

Hindawi Limited

Subject

General Agricultural and Biological Sciences

Link

http://downloads.hindawi.com/journals/crirh/2020/8860492.pdf

Reference15 articles.

1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

2. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?;P. Sarzi-Puttini;Clinical and Experimental Rheumatology,2020

3. Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study

4. Service d’information du gouvernement du Burkina Faso,2020

5. Arrêté 2020-119/MS/CAB portant adoption du protocole national de prise en charge des cas confirmés de COVID-19 intégrant l’hydroxychloroquine et/ou la chloroquine phosphate;Ministère de la santé,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Featured immune characteristics of COVID-19 and systemic lupus erythematosus revealed by multidimensional integrated analyses;Inflammation Research;2023-09

2. Featured immune characteristics of COVID-19 and systemic lupus erythematosus revealed by multidimensional integrated analyses;2023-05-18

3. The impact of the COVID-19 pandemic on SLE;Modern Rheumatology;2023-03-24

4. Pulmonary involvement in connective tissue disease due to Coronavirus 19: a case report;Journal of Health Sciences and Medicine;2021-05-21

5. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic;Rheumatology International;2021-01-03